Ureteral Stents

Ureteral Stents Market Outlook

The global ureteral stents market is projected to reach approximately USD 1.2 billion by 2035, with a compound annual growth rate (CAGR) of around 6.0% during the forecast period from 2025 to 2035. This growth is primarily driven by the increasing prevalence of urinary tract disorders, particularly kidney stones and ureteral obstructions, which necessitate the use of ureteral stents for effective management. Additionally, advancements in medical technologies, increasing demand for minimally invasive procedures, and a growing elderly population are further propelling the market's expansion. An influx of innovative products designed to enhance patient comfort and treatment efficacy is also enhancing the market landscape. As healthcare professionals become more aware of the benefits of stenting in urological procedures, the adoption of ureteral stents is expected to rise significantly, contributing to the overall market growth.

Growth Factor of the Market

One of the primary growth factors driving the ureteral stents market is the increasing incidence of urinary tract disorders, which includes conditions such as benign and malignant ureteral obstructions and kidney stones. The rise in lifestyle-related health issues, such as obesity and diabetes, is contributing to the prevalence of kidney stones, thus increasing the demand for ureteral stents as a treatment option. Furthermore, technological advancements in stent design and materials are enhancing the effectiveness and comfort associated with these devices. The trend towards outpatient procedures and minimally invasive surgeries is also a significant factor encouraging the utilization of ureteral stents, as they facilitate quicker recovery times and shorter hospital stays. Additionally, the growing awareness among patients and healthcare professionals about the benefits of ureteral stenting is expected to further stimulate market growth, as healthcare systems increasingly adopt these devices for efficient treatment.

Key Highlights of the Market

• The ureteral stents market is expected to grow significantly, driven by the increasing prevalence of urinary tract disorders.
• Technological advancements in stent design are enhancing patient comfort and treatment outcomes.
• The trend towards minimally invasive surgeries is promoting the adoption of ureteral stents in clinical practice.
• Growing awareness among patients and healthcare providers is further stimulating market demand.
• The introduction of biodegradable stents presents new opportunities for market expansion and innovation.

By Product Type

Open-Ended Ureteral Stents:

Open-ended ureteral stents are widely used in clinical practice due to their simplicity and effectiveness in relieving obstruction in the urinary tract. These stents feature an open distal end that allows urine to flow freely from the kidney to the bladder, thus maintaining renal function. The design is particularly advantageous for prolonged use, as it minimizes the risk of blockage from sedimentation. Open-ended stents are often utilized in patients with kidney stones or tumors causing ureteral obstruction, and their ease of insertion and removal makes them favorable among healthcare professionals. Additionally, ongoing innovations in materials and coatings for these stents are helping to reduce complications and improve patient outcomes, further solidifying their position in the market.

Closed-Ended Ureteral Stents:

Closed-ended ureteral stents are designed to provide a controlled flow of urine while preventing urinary reflux. This design is beneficial for specific clinical scenarios, such as post-surgical patients or those at high risk for urinary complications. The closed distal end minimizes the risk of infection and allows for better management of ureteral conditions. However, closed-ended stents may require more careful monitoring to prevent blockage due to sediment accumulation. As advancements in stent technology continue to emerge, closed-ended ureteral stents are evolving to include features that enhance patient comfort and reduce complications, thereby expanding their application in urological treatments.

Double-J Ureteral Stents:

Double-J ureteral stents, characterized by their coiled design at both ends, are specifically engineered to prevent displacement and ensure optimal drainage of urine from the kidney to the bladder. The unique design allows for better anchoring within the ureter, minimizing the risk of migration. These stents are commonly utilized in patients undergoing procedures such as ureteroscopy or those with ureteral obstructions due to stones or tumors. The effectiveness of Double-J stents in providing long-term drainage solutions, coupled with their ease of insertion, has made them a popular choice among urologists. With ongoing advancements in materials and design, the demand for Double-J ureteral stents is expected to grow significantly, particularly in outpatient surgical settings.

Multi-Length Ureteral Stents:

Multi-length ureteral stents are designed to accommodate varying anatomical lengths of the ureter, making them a versatile option for urologists dealing with diverse patient needs. These stents can be adjusted to the appropriate length during insertion, providing a customized solution that enhances comfort and minimizes complications. The ability to tailor the stent length not only improves the effectiveness of drainage but also reduces patient discomfort associated with stent migration or dislocation. As the demand for personalized medical solutions continues to rise, multi-length ureteral stents are poised to grow in popularity among healthcare providers looking for adaptable and effective treatment options.

Biodegradable Ureteral Stents:

Biodegradable ureteral stents represent a significant innovation in the field of urology, offering a more sustainable and patient-friendly alternative to traditional stents. These stents are designed to gradually dissolve within the body, eliminating the need for surgical removal after the required treatment duration. This feature not only decreases the burden on healthcare systems but also enhances patient comfort by reducing the risk of complications associated with long-term stent placement. The introduction of biodegradable materials in stent manufacturing is paving the way for safer and more effective treatment options in managing ureteral obstructions and stones. As the market for biodegradable stents expands, they are likely to gain traction among both healthcare providers and patients seeking advanced treatment options.

By Application

Benign Ureteral Obstruction:

Benign ureteral obstruction occurs due to non-cancerous conditions, such as strictures, inflammation, or external compression. Ureteral stents are often employed in these cases to facilitate urine drainage and relieve pressure on the kidneys. The use of stents enables healthcare providers to manage symptoms effectively while minimizing the risk of kidney damage. As the prevalence of benign urinary tract conditions rises, the demand for ureteral stents in this application is expected to increase. Ongoing research and development are focusing on improving stent materials and designs to enhance patient comfort and reduce complications associated with prolonged use, further driving market growth in this segment.

Malignant Ureteral Obstruction:

Malignant ureteral obstruction is often a consequence of cancerous growths that compress or invade the ureter, leading to impaired urine flow. Ureteral stents play a crucial role in palliative care for patients with advanced cancer, as they help alleviate symptoms and improve quality of life. The demand for ureteral stents in this application is driven by the rising incidence of cancers that affect the urinary system, such as bladder, prostate, and cervical cancer. Additionally, advancements in stent technology are enabling better management of malignant obstructions, thereby expanding the market as healthcare providers seek effective solutions for their patients.

Kidney Stone Management:

Kidney stones are a common urological disorder, often requiring intervention to prevent complications such as obstruction or infection. Ureteral stents are frequently used in conjunction with other procedures, such as ureteroscopy or extracorporeal shock wave lithotripsy, to facilitate the passage of stones and ensure proper urine drainage. The increasing prevalence of kidney stones, attributed to factors such as diet and lifestyle changes, is significantly driving the demand for ureteral stents in this application. Furthermore, the development of stents designed specifically for kidney stone management, featuring innovative materials and designs, is expected to enhance treatment outcomes and further propel market growth.

Others:

Aside from benign and malignant ureteral obstructions and kidney stone management, there are various other applications for ureteral stents, including post-surgical care and the management of congenital abnormalities. In these cases, ureteral stents serve to maintain urine flow and prevent complications during the healing process. As healthcare providers explore diverse applications for ureteral stents, the overall market is anticipated to experience continued growth. The versatility of ureteral stents in addressing multiple urological conditions highlights their importance in contemporary medical practice.

By Material Type

Polymer Ureteral Stents:

Polymer ureteral stents are widely utilized in urological procedures due to their flexibility, lightweight nature, and resistance to encrustation. These stents are often made from materials such as polyurethane or polyethylene, which allow for easy insertion and removal. The ability to design these stents in various sizes and shapes enhances their adaptability to different patient anatomies. Polymer stents are particularly favored for their cost-effectiveness and compatibility with minimally invasive surgical techniques. As the demand for effective yet affordable treatment options continues to rise, polymer ureteral stents are expected to maintain a strong presence in the market.

Metal Ureteral Stents:

Metal ureteral stents, typically made from materials such as stainless steel or nitinol, offer durability and strength that can be beneficial in certain clinical scenarios. These stents are often preferred for challenging cases, such as malignant obstructions where longer-term support is necessary. The rigidity of metal stents allows for optimal drainage in patients with complex ureteral anatomies, minimizing the risk of blockage or dislodgment. While metal stents are generally more expensive than their polymer counterparts, their long-term effectiveness and reliability make them a valuable option for healthcare providers managing difficult urological conditions.

Silicone Ureteral Stents:

Silicone ureteral stents are known for their biocompatibility and flexibility, making them a popular choice for temporary drainage in urological procedures. These stents are less likely to cause irritation or inflammation within the urinary tract, which enhances patient comfort during stent placement. Silicone stents are often utilized in acute situations, such as post-operative care or in patients with acute ureteral obstructions. The ability to manufacture these stents in various sizes and configurations allows for customization, thereby improving treatment outcomes. As innovation continues in silicone stent technology, their adoption within urological practice is expected to grow substantially.

Hybrid Ureteral Stents:

Hybrid ureteral stents combine features of various material types to optimize performance and patient outcomes. These stents often incorporate a polymer core with a coating of silicone or other materials to enhance biocompatibility and reduce the risk of encrustation. The hybrid design allows for greater flexibility while still providing the necessary strength for effective urine drainage. As healthcare providers seek more efficient solutions for ureteral obstruction management, hybrid stents are gaining traction due to their tailored performance capabilities. The growing interest in hybrid technologies within the medical device market is likely to drive further innovation and adoption in this segment.

Bioactive Ureteral Stents:

Bioactive ureteral stents are a novel advancement designed to improve patient outcomes through antimicrobial properties and drug delivery capabilities. These stents are engineered to release therapeutic agents that help prevent infection and inflammation during placement. The bioactive features not only enhance patient comfort but also reduce the risk of complications commonly associated with traditional stents. As the focus on patient safety and comfort continues to grow within the healthcare industry, the adoption of bioactive ureteral stents is expected to increase. The ongoing research and development in this area indicate a promising future for bioactive technologies in urological practices.

By User

Hospitals:

Hospitals represent the largest segment in the ureteral stents market due to the extensive range of urological procedures performed in these facilities. Hospitals are equipped with advanced medical technologies and skilled healthcare professionals capable of handling complex cases involving ureteral stents. The prevalence of surgical procedures, such as ureteroscopy and nephrostomy, translates to a high demand for ureteral stents in hospital settings. Additionally, hospitals are increasingly adopting minimally invasive surgical approaches, further driving the need for effective stenting solutions. The emphasis on improving patient outcomes and reducing complications in hospital settings contributes to the sustained growth of the ureteral stents market within this segment.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining prominence in the ureteral stents market, as they provide efficient and cost-effective surgical services for urological conditions. ASCs are equipped to handle a variety of outpatient procedures, including those requiring the placement of ureteral stents. The growing trend towards outpatient surgeries is encouraging patients to seek care in ASCs, where they can benefit from shorter recovery times and lower costs. As the healthcare landscape continues to shift towards patient-centered care, the demand for ureteral stents in ASCs is expected to rise, further contributing to market growth.

Specialty Clinics:

Specialty clinics, focusing on urology and related fields, are increasingly becoming key players in the ureteral stents market. These clinics provide specialized care and treatment for patients with urinary tract conditions, often offering advanced diagnostic and therapeutic options. The concentration of expertise and resources in specialty clinics enables them to manage complex cases effectively, driving demand for ureteral stents. Additionally, as more patients seek specialized care for urological issues, the growth of specialty clinics is anticipated to positively impact the ureteral stents market. The focus on tailored care and innovative treatment options in these clinics enhances their appeal to patients and healthcare providers alike.

Others:

Other end-users of ureteral stents include research institutions and educational facilities where stenting techniques are studied and developed. These organizations play a vital role in advancing the knowledge base of ureteral stent applications and innovations. The involvement of research institutions in clinical trials and product development contributes to the evolution of ureteral stenting technologies, ultimately benefiting the broader market. As the demand for advanced medical education and research continues to grow, the impact of these entities on the ureteral stents market cannot be overlooked.

By Region

The North American ureteral stents market is projected to dominate the global landscape, holding a significant market share due to the region's advanced healthcare infrastructure, high prevalence of urinary tract disorders, and robust research and development activities. The United States, in particular, accounts for a substantial portion of the market, driven by the increasing number of outpatient procedures and demand for minimally invasive surgical solutions. The North American market is expected to grow at a CAGR of around 6.5% over the forecast period, reflecting the strong commitment of healthcare providers to adopt innovative stenting technologies and improve patient outcomes.

In Europe, the ureteral stents market is experiencing steady growth, driven by a rising aging population and an increasing prevalence of chronic diseases leading to urinary tract complications. Countries such as Germany, France, and the United Kingdom are at the forefront of this growth, thanks to their advanced healthcare systems and increasing investments in urological research. The European market is expected to witness a CAGR of approximately 5% in the coming years, as healthcare providers increasingly adopt advanced stenting solutions to enhance patient care and treatment efficacy. Emerging markets in Asia Pacific and Latin America are also anticipated to contribute to the overall growth of the ureteral stents market as healthcare access improves and awareness of urological conditions rises.

Opportunities

The ureteral stents market presents numerous opportunities for growth and innovation, primarily driven by the increasing demand for advanced medical devices that enhance patient outcomes. One significant opportunity lies in the development of biodegradable ureteral stents, which offer a more sustainable alternative to traditional materials. As healthcare providers and patients alike prioritize safety and comfort, the demand for bioactive stents that release therapeutic agents is likely to rise. Additionally, as the incidence of chronic urinary disorders continues to increase, there is an opportunity for manufacturers to invest in research and development to improve stent materials and designs. Collaborations between medical device companies and healthcare institutions for clinical trials can lead to innovative solutions that meet the evolving needs of patients.

Furthermore, expanding healthcare access in emerging markets presents a substantial opportunity for the ureteral stents market. As healthcare systems in regions such as Asia Pacific and Latin America continue to modernize, the demand for effective treatment options for urinary tract conditions will likely increase. Manufacturers that establish partnerships with local distributors and healthcare providers can effectively penetrate these growing markets and cater to the unique needs of patients. Additionally, ongoing education and training programs for healthcare professionals on the latest advancements in ureteral stenting technologies can foster a more knowledgeable workforce, ultimately enhancing patient care and driving market growth.

Threats

The ureteral stents market faces several threats that could impede growth, with one of the most significant being the potential for complications associated with stent placement and long-term use. Complications such as infection, encrustation, and stent migration can result in patient dissatisfaction and increased healthcare costs. As patients become more aware of these risks, there may be a reluctance to undergo stenting procedures, impacting overall market demand. Furthermore, the presence of alternative treatment options, such as laser lithotripsy and other minimally invasive techniques for managing urinary tract conditions, can pose a competitive threat to the ureteral stents market. Manufacturers must continuously innovate and improve their products to address these concerns and maintain market share.

Additionally, regulatory challenges and stringent approval processes for medical devices can pose a restraining factor for manufacturers looking to introduce new ureteral stent technologies. The need for comprehensive clinical trials and adherence to safety standards can delay product launches, affecting market growth. Moreover, economic factors such as fluctuating healthcare budgets and reimbursement policies may impact the financial viability of urological procedures that employ ureteral stents. As healthcare systems around the world seek to reduce costs, the market may experience pressure, leading to potential reductions in stent utilization rates.

Competitor Outlook

• Boston Scientific Corporation
• Cook Medical LLC
• Teleflex Incorporated
• Coloplast A/S
• Medtronic Plc
• Stentys S.A.
• UreSil, Inc.
• Bard Medical Division
• Teleflex Medical
• Inari Medical, Inc.
• AngioDynamics, Inc.
• CeramTec GmbH
• Strata Solutions, LLC
• Argon Medical Devices, Inc.
• Acura Surgical, Inc.

The competitive landscape of the ureteral stents market is characterized by a diverse range of manufacturers and suppliers that are continually striving to innovate and differentiate their products. Leading companies in this market are focusing on research and development initiatives to introduce advanced stenting technologies that address the evolving needs of patients and healthcare providers. Collaborations, partnerships, and strategic acquisitions are common strategies employed by these companies to expand their market presence and enhance their product offerings. As new entrants continue to emerge in the market, established players must maintain their competitive edge by investing in technology and improving product quality to meet regulatory standards and patient expectations.

Boston Scientific Corporation is one of the dominant players in the ureteral stents market, known for its extensive portfolio of urological devices. The company has a strong focus on innovation, with significant investments in research and development to enhance stent design and materials. Their proprietary technologies, including advanced polymer coatings, have enabled the development of stents that minimize complications and enhance patient comfort. Cook Medical LLC, another key player, prides itself on delivering high-quality ureteral stents tailored for a variety of clinical applications. Their focus on patient safety and effectiveness positions them as a trusted provider among healthcare professionals.

Teleflex Incorporated is recognized for its wide range of urological products, including ureteral stents, and has established a reputation for quality and reliability. Their commitment to innovation is evident in the development of advanced stenting solutions that incorporate features such as antimicrobial coatings to reduce infection risks. Medtronic Plc also plays a significant role in the ureteral stents market, with a strong emphasis on minimally invasive technologies and patient-centered care. Their ongoing research in biocompatible materials for ureteral stents demonstrates their dedication to improving patient outcomes and enhancing the overall stenting experience.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Stentys S.A.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 UreSil, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 CeramTec GmbH
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Coloplast A/S
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic Plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Cook Medical LLC
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Teleflex Medical
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 AngioDynamics, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Inari Medical, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Acura Surgical, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bard Medical Division
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Strata Solutions, LLC
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Teleflex Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Argon Medical Devices, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Ureteral Stents Market, By User
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
    • 6.1.4 Others
  • 6.2 Ureteral Stents Market, By Application
    • 6.2.1 Benign Ureteral Obstruction
    • 6.2.2 Malignant Ureteral Obstruction
    • 6.2.3 Kidney Stone Management
    • 6.2.4 Others
  • 6.3 Ureteral Stents Market, By Product Type
    • 6.3.1 Open-Ended Ureteral Stents
    • 6.3.2 Closed-Ended Ureteral Stents
    • 6.3.3 Double-J Ureteral Stents
    • 6.3.4 Multi-Length Ureteral Stents
    • 6.3.5 Biodegradable Ureteral Stents
  • 6.4 Ureteral Stents Market, By Material Type
    • 6.4.1 Polymer Ureteral Stents
    • 6.4.2 Metal Ureteral Stents
    • 6.4.3 Silicone Ureteral Stents
    • 6.4.4 Hybrid Ureteral Stents
    • 6.4.5 Bioactive Ureteral Stents

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Ureteral Stents Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Ureteral Stents market is categorized based on

By Product Type

• Open-Ended Ureteral Stents
• Closed-Ended Ureteral Stents
• Double-J Ureteral Stents
• Multi-Length Ureteral Stents
• Biodegradable Ureteral Stents

By Application

• Benign Ureteral Obstruction
• Malignant Ureteral Obstruction
• Kidney Stone Management
• Others

By Material Type

• Polymer Ureteral Stents
• Metal Ureteral Stents
• Silicone Ureteral Stents
• Hybrid Ureteral Stents
• Bioactive Ureteral Stents

By User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Cook Medical LLC
• Teleflex Incorporated
• Coloplast A/S
• Medtronic Plc
• Stentys S.A.
• UreSil, Inc.
• Bard Medical Division
• Teleflex Medical
• Inari Medical, Inc.
• AngioDynamics, Inc.
• CeramTec GmbH
• Strata Solutions, LLC
• Argon Medical Devices, Inc.
• Acura Surgical, Inc.